Published in Drug Week, July 13th, 2007
Immunotope's IMT-1012 multivalent cancer therapeutic vaccine is the first cancer vaccine to combine 12 different novel antigens that each target a different, critical pathway present in highly aggressive ovarian and breast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.